Effects of Dietary Equol on the Pituitary of the Ovariectomized Rats

 

 Buy Article Permissions and Reprints

Abstract

The aim of our study was to evaluate the effects of dietary equol, metabolite of a phytoestrogen daidzein, on the secretion of prolactin (PRL) and lutenizing hormone (LH), as well as the expression of estrogen receptors (ERα, ERβ and truncated estrogen receptor-1 (TERP-1) in the pituitary gland of ovariectomized (ovx) female Sprague-Dawley rats. Two doses of equol (50 mg/kg of chow and 400 mg/kg of chow) were used and the results were compared with the effects of estradiol 3-benzoate (E2B), also given at two doses (4.3 mg/kg of chow and 17.3 mg/kg of chow). Treatment period was 3 months. Dietary equol administration at the high dose increased significantly serum PRL levels. This effect was also observed in the E2B group but this difference did not reach statistical significance. Surprisingly, high dose dietary equol treatment also significantly increased serum LH levels, which was in contrast to E2B treatment where serum LH levels were significantly decreased at both doses. Serum LH levels in the equol low group were unaffected. Equol treatment had no effects on pituitary ERα or ERβ gene expression. In contrast, high dose E2B treatment increased significantly pituitary ERα mRNA levels but decreased those of ERβ. Both doses of E2B also increased significantly pituitary TERP-1 mRNA levels. This effect was also observed in the equol high group but at a much smaller magnitude. In conclusion, high dose dietary equol administration to ovx rats exerts estrogenic like effects on the lactotropes and anti-estrogenic on the gonadotropes.

References

• 1 Lieberman ME, Maurer RA, Claude P, Wiklund J, Wertz N, Gorski J. Regulation of pituitary growth and prolactin gene expression by estrogen.  Adv Exp Med Biol. 1981;  138 151-163
  PubMedGoogle Scholar
• 2 Lieberman ME, Maurer RA, Gorski J. Estrogen control of prolactin synthesis in vitro.  Proc Natl Acad Sci USA. 1978;  75 5946-5949
  CrossrefPubMedGoogle Scholar
• 3 Nedvidkova J, Kasafirek E, Dlabac A. Effect of enkephalin analogues Tyr-D-Ala-Gly-Phe-Cys(Et) and Tyr-D-Ala-Gly-Phe-Cys(Bu) on prolactin and growth hormone release in rats.  Endocrinol Exp. 1988;  22 255-259
  PubMedGoogle Scholar
• 4 Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade.  Cell. 1995;  83 835-839
  CrossrefPubMedGoogle Scholar
• 5 Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action.  Physiol Rev. 2001;  81 1535-1565
  PubMedGoogle Scholar
• 6 Mitchner NA, Garlick C, Ben-Jonathan N. Cellular distribution and gene regulation of estrogen receptors alpha and beta in the rat pituitary gland.  Endocrinology. 1998;  139 3976-3983
  CrossrefPubMedGoogle Scholar
• 7 Wilson ME, Price Jr RH, Handa RJ. Estrogen receptor-beta messenger ribonucleic acid expression in the pituitary gland.  Endocrinology. 1998;  139 5151-5156
  CrossrefPubMedGoogle Scholar
• 8 Friend KE, Ang LW, Shupnik MA. Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary.  Proc Natl Acad Sci USA. 1995;  92 4367-4371
  CrossrefPubMedGoogle Scholar
• 9 Resnick EM, Schreihofer DA, Periasamy A, Shupnik MA. Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors alpha and beta.  J Biol Chem. 2000;  275 7158-7166
  CrossrefPubMedGoogle Scholar
• 10 Friend KE, Resnick EM, Ang LW, Shupnik MA. Specific modulation of estrogen receptor mRNA isoforms in rat pituitary throughout the estrous cycle and in response to steroid hormones.  Mol Cell Endocrinol. 1997;  131 147-155
  CrossrefPubMedGoogle Scholar
• 11 Schreihofer DA, Resnick EM, Soh AY, Shupnik MA. Transcriptional regulation by a naturally occurring truncated rat estrogen receptor (ER), truncated ER product-1 (TERP-1).  Mol Endocrinol. 1999;  13 320-329
  CrossrefPubMedGoogle Scholar
• 12 Wuttke W, Jarry H, Westphalen S, Christoffel V, Seidlova-Wuttke D. Phytoestrogens for hormone replacement therapy?.  J Steroid Biochem Mol Biol. 2002;  83 133-147
  CrossrefPubMedGoogle Scholar
• 13 Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.  Endocrinology. 1998;  139 4252-4263
  CrossrefPubMedGoogle Scholar
• 14 Miksicek RJ. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor.  J Steroid Biochem Mol Biol. 1994;  49 153-160
  CrossrefPubMedGoogle Scholar
• 15 Marrian G, Haslewood G. Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares urine.  Biochem J. 1932;  26 1227-1232
  CrossrefPubMedGoogle Scholar
• 16 Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.  Bioorg Med Chem. 2004;  12 1559-1567
  CrossrefPubMedGoogle Scholar
• 17 Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.  Nutr Cancer. 2000;  36 27-32
  CrossrefPubMedGoogle Scholar
• 18 Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.  J Nutr. 2003;  133 1027-1035
  PubMedGoogle Scholar
• 19 Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors alpha and beta.  Biol Pharm Bull. 2001;  24 351-356
  CrossrefPubMedGoogle Scholar
• 20 Kaziro R, Kennedy JP, Cole ER, Southwell-Keely PT. The oestrogenicity of equol in sheep.  J Endocrinol. 1984;  103 395-399
  PubMedGoogle Scholar
• 21 Selvaraj V, Zakroczymski MA, Naaz A, Mukai M, Ju YH, Doerge DR, Katzenellenbogen JA, Helferich WG, Cooke PS. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice.  Biol Reprod. 2004;  71 966-972
  CrossrefPubMedGoogle Scholar
• 22 Rachon D, Vortherms T, Seidlova-Wuttke D, Wuttke W. Effects of dietary equol on body weight gain, intraabdominal fat accumulation, plasma lipids and glucose tolerance in ovariectomized Sprague-Dawley rats.  Menopause. 2007;  12 1-8
  PubMedGoogle Scholar
• 23 Roth C, Schricker M, Lakomek M, Strege A, Heiden I, Luft H, Munzel U, Wuttke W, Jarry H. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.  J Endocrinol. 2001;  169 361-371
  CrossrefPubMedGoogle Scholar
• 24 Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR.  Genome Res. 1996;  6 986-994
  PubMedGoogle Scholar
• 25 Seidlova-Wuttke D, Hesse O, Jarry H, Christoffel V, Spengler B, Becker T, Wuttke W. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta.  Eur J Endocrinol. 2003;  149 351-362
  CrossrefPubMedGoogle Scholar
• 26 Odum J, Lefevre PA, Tittensor S, Paton D, Routledge EJ, Beresford NA, Sumpter JP, Ashby J. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay.  Regul Toxicol Pharmacol. 1997;  25 176-188
  CrossrefPubMedGoogle Scholar
• 27 Tang BY, Adams NR. Effect of equol on oestrogen receptors and on synthesis of DNA and protein in the immature rat uterus.  J Endocrinol. 1980;  85 291-297
  PubMedGoogle Scholar
• 28 Chen HT. Postnatal development of pituitary lactotropes in the rat measured by reverse hemolytic plaque assay.  Endocrinology. 1987;  120 247-253
  PubMedGoogle Scholar
• 29 Dada MO, Campbell GT, Blake CA. A quantitative immunocytochemical study of the luteinizing hormone and follicle-stimulating hormone cells in the adenohypophysis of adult male rats and adult female rats throughout the estrous cycle.  Endocrinology. 1983;  113 970-984
  PubMedGoogle Scholar
• 30 Levine JE. New concepts of the neuroendocrine regulation of gonadotropin surges in rats.  Biol Reprod. 1997;  56 293-302
  CrossrefPubMedGoogle Scholar
• 31 Shupnik MA, Gordon MS, Chin WW. Tissue-specific regulation of rat estrogen receptor mRNAs.  Mol Endocrinol. 1989;  3 660-665
  PubMedGoogle Scholar
• 32 Schreihofer DA, Stoler MH, Shupnik MA. Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: estrogen decreases ERalpha protein and estrogen responsiveness.  Endocrinology. 2000;  141 2174-2184
  CrossrefPubMedGoogle Scholar
• 33 Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy.  Endocrinology. 1975;  96 219-226
  CrossrefPubMedGoogle Scholar
• 34 Scully KM, Gleiberman AS, Lindzey J, Lubahn DB, Korach KS, Rosenfeld MG. Role of estrogen receptor-alpha in the anterior pituitary gland.  Mol Endocrinol. 1997;  11 674-681
  CrossrefPubMedGoogle Scholar
• 35 Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake.  J Epidemiol. 2000;  10 127-135
  PubMedGoogle Scholar
• 36 Faure ED, Chantre P, Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study.  Menopause. 2002;  9 329-334
  CrossrefPubMedGoogle Scholar
• 37 Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.  Menopause. 2000;  7 236-242
  CrossrefPubMedGoogle Scholar
• 38 Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial.  J Clin Oncol. 2000;  18 1068-1074
  PubMedGoogle Scholar
• 39 Davidson IW, Parker JC, Beliles RP. Biological basis for extrapolation across mammalian species.  Regul Toxicol Pharmacol. 1986;  6 211-237
  CrossrefPubMedGoogle Scholar
• 40 Vocci F, Farber T. Extrapolation of animal toxicity data to man.  Regul Toxicol Pharmacol. 1988;  8 389-398
  CrossrefPubMedGoogle Scholar
• 41 Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.  Am J Clin Nutr. 2005;  81 1072-1079
  PubMedGoogle Scholar

Correspondence

Dr. D. RachońM.D., Ph.D. 

Department of Immunology

Medical University of Gdańsk

ul. Dębinki 1

80-210 Gdańsk

Poland

Phone: +48/58/349 15 35

Fax: +48/58/349 25 03

Email: drachon@amg.gda.pl